TickerFactsScreenerDevelopers

Kyverna Therapeutics, Inc. (KYTX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2023: $34.65M2024: $96.62M2025: $124.09M$124.09M
2023Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$124.09M+28.4%
2024$96.62M+178.9%
2023$34.65M—